Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 19/20 | 0.40 |
| ▸ | CA2 | P00918 | 19/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3812152 | 0.83 | NOS3 (0.39) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL3056410 | 0.81 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| Water SCHEMBL21810558 | 0.81 | NOS3 (0.38) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL19152428 | 0.81 | CA1 (0.42) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL13897077 | 0.81 | NOS3 (0.38) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL5326458 | 0.79 | NOS3 (0.37) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL28254066 | 0.79 | NOS3 (0.37) | CA1CA2NOS3NOS1NOS2 | |
| Creatine SCHEMBL21567 | 0.78 | — | — | |
| Creatine SCHEMBL30063981 | 0.78 | — | — | |
| Creatine SCHEMBL27979093 | 0.78 | NOS3 (0.46) | CA1CA2NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106011163-A | Method for cell-free expression of signal protein and expression system | 武汉华美生物工程有限公司 | 2016-10-12 | — | — | CN | claimed |
| CN-110408635-A | A kind of application of the nucleic acid constructs containing Streptavidin element in protein expression, purifying | KANGMA SHANGHAI BIOTECHNOLOGY CO LTD | 2019-11-05 | — | — | CN | disclosed |
| CN-108949801-B | A method of by knocking out nucleic acid enzyme system to regulate and control external biological synthesizing activity | 康码（上海）生物科技有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109837293-A | A kind of series connection DNA element that can enhance protein synthesis efficiency | 康码（上海）生物科技有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109154001-A | Novel minimal UTR sequences | 埃泽瑞斯公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-103768037-B | There is antitumor and reduction induced cardiotoxicity slow releasing pharmaceutical nanoparticle and preparation method thereof by carrier of amphiphilic compound | 华南理工大学 | 2017-10-20 | — | — | CN | disclosed |
| CN-103098561-B | The manufacture method of stiffener integral type flexible printing substrate and stiffener integral type flexible printing substrate | KANEKA CORP. (JP) | 2015-11-25 | — | — | CN | disclosed |
| US-20140350497-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2014-11-27 | — | — | US | disclosed |
| CN-103990184-A | Device and method for treating central nervous system pathology | WAKE FOREST UNIVERSITY HEATH SCIENCES | 2014-08-20 | — | — | CN | disclosed |
| US-8764794-B2 | Device and method for treating central nervous system pathology | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2014-07-01 | — | — | US | disclosed |
| US-20130072827-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2013-03-21 | — | — | US | disclosed |
| US-8267960-B2 | Device and method for treating central nervous system pathology | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2012-09-18 | — | — | US | disclosed |
| CN-102014980-A | Devices and methods for treating central nervous system pathologies | UNIV WAKE FOREST HEALTH SCIENCES | 2011-04-13 | — | — | CN | disclosed |
| EP-2237812-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | Wake Forest University Health Sciences (US) | 2010-10-13 | — | — | EP | disclosed |
| CN-101084937-B | Ginkgo leaves freezing-dried powder injection and preparation method thereof | ZHENBAODAO PHARMACEUTICAL CO LTD HEILONGJIANG PROV | 2010-06-30 | — | — | CN | disclosed |
| US-20090254120-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2009-10-08 | — | — | US | disclosed |
| WO-2009089435-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2009-07-16 | — | — | WO | disclosed |
| CN-101084937-A | Ginkgo leaves freezing-dried powder injection and preparation method thereof | HEILONGJIANG ZHENBAODAO PHARMA (CN) | 2007-12-12 | — | — | CN | disclosed |
| US-5130119-A | Sulfonamide or hydroxy fluorine substituted benzene for medical diagnosis | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-07-14 | — | — | US | disclosed |
| US-4959612-A | Method of heteronuclear decoupling in magnetic resonance spectroscopy, and device for determining a spectrum | U.S. PHILIPS CORPORATION (US) | 1990-09-25 | — | — | US | disclosed |